08222017Headline:

Wilmington, North Carolina

HomeNorth CarolinaWilmington

Email Jean Martin Jean Martin on LinkedIn Jean Martin on Twitter Jean Martin on Facebook
Jean Martin
Jean Martin
Contributor •

More Digoxin Tablets Recalled

Comments Off

Caraco Pharmaceutical Laboratories, Ltd. announced yesterday that it was recalling all of its Digoxin 0.125 mg and 0.25 mg tablets. Caraco Pharmaceutical Laboratories manufacturers generic pharmaceuticals. Only the generic Digoxin tablets manufactured by Caraco are subject to this recall.

These Digoxin tablets are being recalled because they differ in size and may contain more or less of the active ingredient, digoxin, than they should. Too much digoxin can cause a risk of toxicity, particularly in patients with renal failure. Digoxin toxicity can cause nausea, vomiting, dizziness, low blood pressure and cardiac instability. Death can also result.

Digoxin is used to treat heart failure and abnormal heart rhythms. Just about a year ago, other digoxin tables were recalled because of a manufacturing problem resulting in pills containing twice as much medication as was intended.

Consumers with the following Digoxin tablets should return them to the pharmacy where purchased:

Caraco Digoxin 0.125 mg is a scored round biconvex yellow tablet imprinted with “437”

Caraco Digoxin 0.25 mg is a scored round biconvex white tablet imprinted with “441”

If you are a digoxin patient and have experienced any of the side effects listed above, you should contact your doctor immediately.